Cleveland v. Ludwig Institute for Cancer Research Ltd

District Court, S.D. California·Decided October 27, 2021·No. 3:19-cv-02141·Unknown

Opinion

DON CLEVELAND, et al., Case No.: 19-cv-02141-JM (JLB)

Plaintiffs, [REDACTED] ORDER GRANTING v. IN PART AND DENYING IN PART DEFENDANTS/ COUNTER- CLAIMANTS’ MOTION FOR RESEARCH LTD., et al., SANCTIONS FOR PLAINTIFFS’ Defendants. VIOLATION OF THIS COURT’S PROTECTIVE ORDER [ECF No. 80]

Before the Court is a motion for sanctions filed by Defendants/Counter-Claimants Ludwig Institute for Cancer Research Ltd. (“Ludwig”), Chi Van Dang, Edward A. McDermott, Jr., and John L. Notter (collectively, “Defendants”). (ECF No. 80.) Defendants move for an order sanctioning Plaintiffs/Counter-Defendants Don Cleveland, Arshad Desai, Frank Furnari, Richard Kolodner (“Kolodner”), Paul Mischel, Karen Oegema, and Bing Ren (collectively, “Plaintiffs”) for violations of the Protective Order issued in this case. (Id. at 2.) Plaintiffs filed an opposition. (ECF No. 83.) Defendants filed a reply. (ECF No. 85.) For the reasons set forth below, the Court GRANTS IN PART and DENIES IN PART Defendants’ motion for sanctions. /// A. Ludwig I On November 7, 2019, Plaintiffs commenced the above-captioned action, Cleveland, et al. v. Ludwig Institute for Cancer Research Ltd, et al., Case No. 19-cv-02141- JM-JLB (S.D. Cal.) (“Ludwig I”). (ECF No. 1.) On July 8, 2020, Plaintiffs filed a Second Amended Complaint (“SAC”), the operative complaint. (ECF No. 26.) According to the SAC, Plaintiffs are internationally acclaimed cancer research scientists and physicians. (SAC ¶ 1.) Ludwig is an international nonprofit organization dedicated to finding a cure for cancer that operates multiple cancer research branches. (Id. ¶¶ 1, 142.) In 1991, Ludwig entered into an “Affiliation Agreement” (“the AA”) with the University of California at San Diego (“UCSD”) to establish a San Diego Branch (“the Branch”). (Id. ¶ 51.) Ludwig agreed to conduct “active” and “continuous” medical research to “discover, develop, or verify knowledge related to causes, diagnoses, treatment, prevention and control of cancer.” (Id. ¶ 53.) Ludwig also agreed to “bear the costs directly related to conducting the research program.” (Id. ¶ 62.) The term of the AA is coterminous with a lease agreement for research facilities between Ludwig and UCSD, which allows Ludwig to terminate the lease no earlier than December 31, 2023. (Id. ¶¶ 4, 16, 56.) In addition to leasing its facilities to Ludwig, UCSD agreed to: (1) grant privileges for the practice of medicine at its hospital to qualified members of the medical staff at the Branch; (2) grant “academic recognition and titles” to qualified Ludwig employees; and (3) make full time equivalency positions available for Ludwig employees. (Id. ¶ 154.) Between 1996 and 2016, Ludwig hired Plaintiffs to work at the Branch. (Id. ¶¶ 26– 32.) In 2018, Ludwig announced that it would “cease funding the Branch and otherwise halt the ‘continuous active conduct of medical research’ at the Branch.” (Id. ¶ 15.) Effective January 1, 2020, Ludwig “terminated all funding for Plaintiffs’ laboratories.” (Id. ¶ 18.) However, “Ludwig continues to fund at least part of the rent due [to UCSD] and it continues to pay the Plaintiffs’ own salaries and benefits, but nothing more.” (Id.) As a result, Plaintiffs’ “[l]aboratories and ongoing translational research programs have ceased or substantially curtailed ongoing research projects, except to the extent that they have access to outside grants.” (Id.) In their SAC, Plaintiffs asserted the following claims against Ludwig: (1) breach of the AA; (2) breach of Plaintiffs’ Intellectual Property (“IP”) agreements; (3) breach of Plaintiffs’ lab contracts; (4) breach of the implied covenant of good faith and fair dealing; (5) promissory estoppel under the AA; (5) declaratory relief; and (6) false light. (SAC ¶¶ 145–70, 182–303.) Plaintiffs also bring a claim against all Defendants for defamation per se. (Id. ¶¶ 171–81.) On November 25, 2020, the Honorable Jeffrey T. Miller dismissed Plaintiffs’ claims for breach of the AA and breach of Plaintiffs’ IP agreements. (ECF No. 32 at 28.) He also dismissed Plaintiffs’ declaratory relief claim with respect to Plaintiffs’ claims based on the AA and IP agreements, and their claim for breach of the implied covenant in the AA and lab contracts. (Id.) B. Ludwig II On May 5, 2021, Plaintiffs filed a separate lawsuit against Ludwig: Cleveland, et al. v. Ludwig Institute for Cancer Research Ltd., Case No. 21-cv-00871-JM-JLB (S.D. Cal.) (“Ludwig II”). (Ludwig II, ECF No. 1.) In Ludwig II, Plaintiffs bring claims against Ludwig for: (1) retaliation in violation of California Government Code § 12940(h); (2) age discrimination under the Fair Employment and Housing Act (“FEHA”); (3) wrongful adverse employment action in violation of public policy; (4) failure to timely pay wages; and (5) violation of California’s unfair competition laws. (Id. at 13–21.) Kolodner also brings a separate claim for retaliation in violation of California Labor Code § 1102.5. (Id. at 12–13.) On May 12, 2021, Ludwig II was low number transferred to Judge Miller and the undersigned judge for all further proceedings. (ECF No. 4.) On July 2, 2021, Judge Miller denied Plaintiffs’ motion to consolidate Ludwig I and Ludwig II. (ECF No. 13.) On July 6, 2021, Ludwig filed a motion to dismiss all claims in the Ludwig II complaint pursuant to Federal Rule of Civil Procedure 12(b)(6). (ECF No. 14.) No answer has been filed. /// C. Protective Order On February 19, 2021, the parties filed a joint motion for entry of stipulated protective order in Ludwig I. (ECF No. 44.) The proposed protective order was largely based on the Southern District of California’s model protective order, which is available on the district court’s website. The proposed protective order also contained the undersigned judge’s required language, as set forth in her Civil Chambers Rules. See J. Burkhardt Civ. Chambers R. § VI.B. On February 22, 2021, the Court granted the joint motion and entered the parties’ stipulated protective order (“Protective Order”). (ECF No. 45.) The Protective Order was entered for the purpose of protecting the confidentiality of documents and information that are, for competitive reasons, normally kept confidential by the parties. (Id. at 1.) These materials “may contain trade secret or other confidential research, technical, cost, price, marketing or other commercial information, as is contemplated by Federal Rule of Civil Procedure 26(c)(1)(G).” (Id. at 2.) To serve this purpose, the Protective Order permits each party to the litigation to designate materials as “CONFIDENTIAL” or “CONFIDENTIAL—FOR COUNSEL ONLY.” (Id. ¶ 4.) The Protective Order permits the designations as follows: a. Designation as “CONFIDENTIAL”: Any party or non-party subject to this Order may designate documents or other information in this action as “CONFIDENTIAL” only if the designating party or non-party and their counsel has an articulable, good faith basis to believe that each document or other information designated as “CONFIDENTIAL” qualifies for protection under Federal Rule of Civil Procedure 26(c). b. Designation as “CONFIDENTIAL—FOR COUNSEL ONLY”: Any party or non-party subject to this Order may designate documents or other information as “CONFIDENTIAL—FOR COUNSEL ONLY” only if the designating party or non-party and their counsel has an articulable, good faith basis to believe that the documents or other information in this action designated as “CONFIDENTIAL—FOR COUNSEL ONLY” qualify for protection under Federal Rule of Civil Procedure 26(c) and are otherwise among that considered to be most sensitive by the

Free access — add to your briefcase to read the full text and ask questions with AI

Cleveland v. Ludwig Institute for Cancer Research Ltd, (S.D. Cal. 2021).

Cleveland v. Ludwig Institute for Cancer Research Ltd (Cleveland v. Ludwig Institute for Cancer Research Ltd) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Chambers v. Nasco, Inc.
501 U.S. 32 (Supreme Court, 1991)
United States v. Alfred Glass
720 F.2d 21 (Eighth Circuit, 1983)
R & R Sails, Inc. v. Insurance Co. of Pennsylvania
673 F.3d 1240 (Ninth Circuit, 2012)
Marine Midland Realty Credit Corp. v. LLMD of Michigan, Inc.
821 F. Supp. 370 (E.D. Pennsylvania, 1993)
On Command Video Corp. v. LodgeNet Entertainment Corp.
976 F. Supp. 917 (N.D. California, 1997)
Kashani v. TSANN KUEN CHINA ENTERPRISE CO.
13 Cal. Rptr. 3d 174 (California Court of Appeal, 2004)
Gomez v. Vernon
255 F.3d 1118 (Ninth Circuit, 2001)
In re Vitamins Antitrust Litigation
211 F.R.D. 1 (District of Columbia, 2002)
Pacific Lumber Co. v. National Union Fire Insurance
220 F.R.D. 349 (N.D. California, 2003)
CBS Interactive, Inc. v. Etilize, Inc.
257 F.R.D. 195 (N.D. California, 2009)
Stein v. Board of City of New York
792 F.2d 13 (Second Circuit, 1986)